SCHEMBL4665704

SCHEMBL4665704

CCCCN(CCCC)c1cccc(CCl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 5/20 0.41
NR1H3 Q13133 5/20 0.41
MAPT P10636 2/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
CNR2 P34972 1/20 0.38
DRD2 P14416 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8664260 0.83 ALDH1A1 (0.45) NR1H2NR1H3MAPTALDH1A1KDM4E
SCHEMBL4663824 0.83 S1PR1 (0.48) NR1H2NR1H3ALDH1A1KDM4EPOLB
SCHEMBL20171826 0.79 ALDH1A1 (0.44) NR1H2NR1H3ALDH1A1GRIN2DGRIN3B
SCHEMBL11133767 0.79 MAPT (0.65) NR1H2NR1H3MAPTALDH1A1KDM4E
SCHEMBL4870098 0.78 EGFR (0.49) NR1H2NR1H3MAPTALDH1A1CNR2
SCHEMBL11000207 0.78 ALDH1A1 (0.55) NR1H2NR1H3MAPTALDH1A1KDM4E
SCHEMBL15592515 0.77 NOS1 (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22589015 0.77 S1PR1 (0.46) NR1H2NR1H3ALDH1A1DRD2OPRM1
SCHEMBL5284253 0.77 ALDH1A1 (0.50) NR1H2NR1H3MAPTALDH1A1KDM4E
Hydrochloric Acid SCHEMBL3373755 0.77 EGFR (0.47) NR1H2NR1H3MAPTALDH1A1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080122428-A1 Optimized Determination of Voltage Changes Using a Voltage-Sensitive Dye MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNGDER WISSENSCHAFTEN E. V. (DE) 2008-05-29 US disclosed
EP-1644722-A1 OPTIMIZED DETERMINATION OF VOLTAGE CHANGES USING A VOLTAGE-SENSITIVE DYE Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2006-04-12 EP disclosed
WO-2005001448-A1 OPTIMIZED DETERMINATION OF VOLTAGE CHANGES USING A VOLTAGE-SENSITIVE DYE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2005-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080122428-A1 Optimized Determination of Voltage Changes Using a Voltage-Sensitive Dye HVCN1, CACNG5, CACNB4 NR1H2 4042/4885NR1H3 3858/4885MAPT 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.